Page 3 - Sight Sciences Daily News Today

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 428,800 shares, a growth of 14.7% from the June 30th total of 373,700 shares. Based on an average trading volume of 120,700 shares, […]

Citigroup lowered shares of Sight Sciences (NASDAQ:SGHT – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Monday morning, Marketbeat reports. Citigroup currently has $9.00 price objective on the stock, down from their prior price objective of $15.00. Several other analysts also recently issued reports on […]

Citigroup cut shares of Sight Sciences (NASDAQ:SGHT – Free Report) from a buy rating to a neutral rating in a research report report published on Monday, MarketBeat Ratings reports. Citigroup currently has $9.00 price target on the stock, down from their prior price target of $15.00. A number of other research analysts have also issued […]

Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among […]

Sight Sciences (NASDAQ:SGHT – Free Report) had its price target lowered by Stifel Nicolaus from $15.00 to $13.00 in a report issued on Monday, The Fly reports. Separately, Bank of America reduced their price objective on shares of Sight Sciences from $13.00 to $10.00 in a research note on Tuesday, June 6th. Two investment analysts […]

Sight Sciences (NASDAQ:SGHT – Free Report) and Imagin Medical (OTCMKTS:IMEXF – Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Profitability This table compares Sight Sciences and Imagin Medical’s net […]

Sight Sciences (NASDAQ:SGHT – Free Report) had its target price lowered by Stifel Nicolaus from $15.00 to $13.00 in a report released on Monday, The Fly reports. Separately, Bank of America lowered their target price on Sight Sciences from $13.00 to $10.00 in a research note on Tuesday, June 6th. Two investment analysts have rated […]

Sight Sciences (NASDAQ:SGHT – Get Rating) and Nyxoah (NASDAQ:NYXH – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of current recommendations for […]

Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) have been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]

Sight Sciences (NASDAQ:SGHT – Get Rating) had its price target cut by Bank of America from $13.00 to $10.00 in a research report report published on Tuesday, The Fly reports. Sight Sciences Trading Down 1.8 % Shares of Sight Sciences stock opened at $7.81 on Tuesday. The firm has a 50-day simple moving average of […]